Lynparza is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Olaparib.
| Product ID | 0310-0668_1843c04f-c7f4-44a3-a8be-7b346e015616 |
| NDC | 0310-0668 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lynparza |
| Generic Name | Olaparib |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-08-17 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208558 |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | OLAPARIB |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Poly(ADP-Ribose) Polymerase Inhibitor [EPC],Poly(ADP-Ribose) Polymerase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2017-08-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208558 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-08-17 |
| Marketing Category | NDA |
| Application Number | NDA208558 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-08-17 |
| Ingredient | Strength |
|---|---|
| OLAPARIB | 100 mg/1 |
| SPL SET ID: | 741ff3e3-dc1a-45a6-84e5-2481b27131aa |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0310-0657 | Lynparza | olaparib |
| 0310-0668 | Lynparza | olaparib |
| 0310-0679 | Lynparza | olaparib |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LYNPARZA 86476170 4991136 Live/Registered |
AstraZeneca AB 2014-12-10 |
![]() LYNPARZA 86190624 4903563 Live/Registered |
AstraZeneca AB 2014-02-11 |